Knee Osteoarthritis Clinical Trial
Official title:
Single-center, Randomized, Open Label, Negative-controlled Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC(Autologous Adipose Tissue Derived Mesenchymal Stem Cells) After High Tibial Osteotomy Compared to Negative Control in the Osteoarthritis Patients.
NCT number | NCT03000712 |
Other study ID # | HTO-MSCs |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | November 2, 2016 |
Est. completion date | May 22, 2020 |
Verified date | June 2019 |
Source | R-Bio |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to evaluate the efficacy and safety of intra-articular injection of autologous adipose tissue derived mesenchymal stem cells compared after high tibial osteotomy to negative control in the osteoarthritis patients
Status | Completed |
Enrollment | 26 |
Est. completion date | May 22, 2020 |
Est. primary completion date | May 22, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 80 Years |
Eligibility | Inclusion Criteria: 1. Patients must consent in writing to participate in the study by signing and dating an informed consent document 2. Patients who can communicate (exclusion of anyone who cannot understand the questionnaire) 3. between 20 years and 80 years of age 4. BMI=30 5. Diagnosis of osteoarthritis by radiographic criteria of Kellgren and Lawrence grade 2-4 6. Diagnosis of osteoarthritis by ACR(American College of Rheumatology Criteria) Global functional criteria : There is the pain of the knee and radiographic osteophyte and at least one of the following (1) age >50 years (2) Less than 30 minutes of morning stiffness (3) The friction When moving weighted the knee 7. Patients who agree with contraception 8. Patients who agree to stop the existing osteoarthritis treatment and to get enough washout periods until medication time 9. Patients scheduled for High tibial osteotomy due to medial gonarthrosis Exclusion Criteria: 1. patients with osteoporosis 2. Preparing for Pregnancy or Pregnant women or lactating mothers. 3. Patients with positive human immunodeficiency (HIV), hepatitis B (HBV), hepatitis C (HCV), venereal disease research laboratory(VDRL) 4. Patients with hypersensitivity to investigator product or investigational product component or those with a history 5. Patients who had participated in other clinical trials within 12 weeks prior to this study 6. Patients who received any drug by intra-articular injection for treatment within 2 months prior to this enrollment. 7. Patients who experienced as the knee joint cartilage and stem cell therapy or failure to treat 8. Patents who started or changed the physical therapy program established within 2 weeks before the start of the study or during the study(An established physical therapy program may continue for the duration of the trial, provided that it does not change in frequency and intensity) 9. Patents included in the following specific risk groups that may influence safety and efficacy assessments at the discretion of the investigator:: septic arthtritis, rheumatic disease, gout, recurrent pseudogout, paget disease, joint fracture, alcaptonuria, acromegaly, hemochromatosis, wilson's disease, primary osteochondrosis, hereditary disorder(ex: hyperkinesia), collagen gene abnormality ,etc 10. Patients who have clinically significant severe medical illnesses judged the principal investigator 11. Patients who have been diagnosed with malignancy within 5 years before screening (except for patients who were completely remissioned three years before screening criteria) 12. Patients who the principal investigator consider inappropriate for the clinical trial due to any other reasons 13. Patients who received concomitant contraindications and who have not passed the prescribed wash-out period before participating in the clinical trial |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | KyungHee University Gangdong Hospital | Seoul |
Lead Sponsor | Collaborator |
---|---|
R-Bio |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | MRI scan | MRI perform to measure cartilage defect size change from baseline up to 27 weeks | 24 months | |
Secondary | MRI scan | MRI perform to measure cartilage defect size change from baseline up to 15 weeks | 15, 27 weeks, 18, 24 months | |
Secondary | WOMAC score | Change in WOMAC Total score from baseline up to 15, 27 weeks | 15, 27 weeks, 18, 24 months | |
Secondary | WOMAC sub-scale | Change in WOMAC sub-scale from baseline up to 15, 27 weeks | 15, 27 weeks, 18, 24 months | |
Secondary | Kellgren & Lawrence grade | Change in Kellgren & Lawrence grade from baseline up to 15, 27 weeks | 15, 27 weeks, 18, 24 months | |
Secondary | EQ5D | Change in the score of EQ-5D from baseline up to 15, 27 weeks | 15, 27 weeks, 18, 24 months | |
Secondary | ROM | change from baseline in knee flexion Range of Motion(ROM) at 15,27 weeks by physical examination | 15, 27 weeks, 18, 24 months | |
Secondary | KOOS (Knee Injury & Osteoarthritis Outcome Score) | Symptoms, pain and functionality of the knee joint will be evaluated via the Knee Injury and Osteoarthritis Outcome Score (KOOS) | 15, 27 weeks, 18, 24 months | |
Secondary | PGIC(Patient Global Impression of Change) | The percentage of subjects who were evaluated as improved at 15 weeks and 27 weeks in the patient global impression of change | 15, 27 weeks, 18, 24 months | |
Secondary | PSQI(Pittsburgh Sleep Quality Index) | Change in PSQI from baseline up to 15, 27 weeks | 15, 27 weeks, 18, 24 months | |
Secondary | Biomarkers | Change from baseline in Biomarkers up to 15, 27 weeks | 15, 27 weeks, 18, 24 months | |
Secondary | Incidence of adverse reactions and characteristics associated with investigational product | 15, 27 weeks, 18, 24 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04651673 -
Prescribed Knee Brace Treatments for Osteoarthritis of the Knee (Knee OA)
|
||
Completed |
NCT05677399 -
Knee Osteoarthritis Treatment With Peloidotherapy and Aquatic Exercise.
|
N/A | |
Active, not recruiting |
NCT04043819 -
Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis
|
Phase 1 | |
Recruiting |
NCT06000410 -
A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee
|
Phase 3 | |
Completed |
NCT05014542 -
Needling Techniques for Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT05892133 -
Prehabilitation Effect on Function and Patient Satisfaction Following Total Knee Arthroplasty
|
N/A | |
Recruiting |
NCT05528965 -
Parallel Versus Perpendicular Technique for Genicular Radiofrequency
|
N/A | |
Active, not recruiting |
NCT03472300 -
Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
|
||
Active, not recruiting |
NCT02003976 -
A Randomized Trial Comparing High Tibial Osteotomy Plus Non-Surgical Treatment and Non-Surgical Treatment Alone
|
N/A | |
Active, not recruiting |
NCT04017533 -
Stability of Uncemented Medially Stabilized TKA
|
N/A | |
Completed |
NCT04779164 -
The Relation Between Abdominal Obesity, Type 2 Diabetes Mellitus and Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT04006314 -
Platelet Rich Plasma and Neural Prolotherapy Injections in Treating Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT05423587 -
Genicular Artery Embolisation for Knee Osteoarthritis II
|
N/A | |
Enrolling by invitation |
NCT04145401 -
Post Market Clinical Follow-Up Study- EVOLUTION® Revision CCK
|
||
Active, not recruiting |
NCT03781843 -
Effects of Genicular Nerve Block in Knee Osteoarthritis
|
N/A | |
Completed |
NCT05974501 -
Pre vs Post Block in Total Knee Arthroplasty (TKA)
|
Phase 4 | |
Completed |
NCT05324163 -
Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis
|
Phase 3 | |
Completed |
NCT05529914 -
Effects of Myofascial Release and Neuromuscular Training for Pes Anserine Syndrome Associated With Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT05693493 -
Can Proprioceptive Knee Brace Improve Functional Outcome Following TKA?
|
N/A | |
Not yet recruiting |
NCT05510648 -
Evaluation of the Effect of High-intensity Laser Therapy in Knee Osteoarthritis
|
N/A |